Copyright
©The Author(s) 2025.
World J Diabetes. Apr 15, 2025; 16(4): 99151
Published online Apr 15, 2025. doi: 10.4239/wjd.v16.i4.99151
Published online Apr 15, 2025. doi: 10.4239/wjd.v16.i4.99151
Table 1 General data and laboratory test indicators, mean ± SD/n (%)
Characteristic | Control group (n = 48) | Observation group (n = 55) | χ2/t value | P value |
Age (years) | 61.21 ± 10.21 | 65.20 ± 9.96 | 2.006 | 0.048 |
Sex | 0.173 | 0.677 | ||
Male | 29 (60.42) | 31 (56.36) | ||
Female | 19 (39.58) | 24 (43.64) | ||
History of smoking and drinking | 0.109 | 0.741 | ||
With | 26 (54.17) | 28 (50.91) | ||
Without | 22 (45.83) | 27 (49.09) | ||
Family history of coronary heart disease | 2.746 | 0.098 | ||
With | 15 (31.25) | 26 (47.27) | ||
Without | 33 (68.75) | 29 (52.73) | ||
BMI (mmol/L) | 23.15 ± 2.69 | 24.09 ± 2.74 | 1.752 | 0.083 |
FBG (mmol/L) | 10.58 ± 2.87 | 14.72 ± 3.92 | 6.038 | 0.000 |
TG (mmol/L) | 2.09 ± 0.79 | 2.41 ± 0.82 | 2.015 | 0.047 |
TC (mmol/L) | 5.82 ± 1.08 | 6.18 ± 1.12 | 1.655 | 0.101 |
HDL-C (mmol/L) | 1.13 ± 0.52 | 1.24 ± 0.48 | 1.116 | 0.267 |
LDL-C (mmol/L) | 2.98 ± 0.57 | 3.22 ± 0.63 | 2.017 | 0.046 |
SCr (μmol/L) | 62.77 ± 10.87 | 63.76 ± 11.25 | 0.453 | 0.652 |
BUN (mmol/L) | 5.49 ± 1.14 | 6.05 ± 1.58 | 2.035 | 0.044 |
ALT (U/L) | 25.88 ± 5.92 | 27.71 ± 6.31 | 1.511 | 0.134 |
AST (U/L) | 24.72 ± 6.74 | 25.41 ± 6.17 | 0.542 | 0.589 |
Table 2 Comparison of coronary imaging characteristics between control and observation group, n (%)
Characteristic | Control group (n = 48) | Observation group (n = 55) | χ2 value | P value |
Diffuse lesion | 15.420 | 0.000 | ||
With | 12 (25.00) | 35 (63.64) | ||
Without | 36 (75.00) | 20 (36.36) | ||
Degree of stenosis | 6.399 | 0.041 | ||
Moderate | 24 (50.00) | 15 (27.27) | ||
Severe | 13 (27.08) | 17 (30.91) | ||
Occlusion | 11 (22.92) | 23 (41.82) |
Table 3 Comparison of stenosis index between control and observation group, mean ± SD
Characteristic | Control group (n = 48) | Observation group (n = 55) | t value | P value |
RCA stenosis index | 2.57 ± 1.07 | 3.98 ± 1.05 | 6.730 | 0.000 |
LCX stenosis index | 2.09 ± 1.12 | 3.37 ± 1.14 | 5.738 | 0.000 |
LAD stenosis index | 3.38 ± 1.32 | 3.59 ± 1.08 | 0.890 | 0.376 |
LMT stenosis index | 1.05 ± 0.41 | 0.97 ± 0.33 | 1.096 | 0.275 |
Total stenosis index | 9.09 ± 2.12 | 11.91 ± 1.94 | 7.049 | 0.000 |
Table 4 Comparison of coronary imaging characteristics in males and females, n (%)
Characteristic | Male (n = 60) | Female (n = 43) | χ2 value | P value |
Diffuse lesion | 1.837 | 0.175 | ||
With | 24 (40.00) | 23 (53.49) | ||
Without | 36 (60.00) | 20 (46.51) | ||
Degree of stenosis | 2.898 | 0.235 | ||
Moderate | 23 (38.33) | 16 (37.21) | ||
Severe | 14 (23.33) | 16 (37.21) | ||
Occlusion | 23 (38.33) | 11 (25.58) |
Table 5 Comparison of stenosis index in males and females, mean ± SD
Characteristic | Male (n = 60) | Female (n = 43) | t value | P value |
RCA stenosis index | 3.28 ± 1.31 | 3.39 ± 1.22 | 0.432 | 0.666 |
LCX stenosis index | 2.91 ± 1.31 | 2.59 ± 1.27 | 1.238 | 0.219 |
LAD stenosis index | 3.45 ± 1.13 | 3.55 ± 1.29 | 0.417 | 0.677 |
LMT stenosis index | 1.01 ± 0.36 | 1.00 ± 0.39 | 0.134 | 0.894 |
Total stenosis index | 10.64 ± 2.48 | 10.53 ± 2.47 | 0.222 | 0.825 |
Table 6 Comparison of hypoglycemic treatment history and glycosylated hemoglobin levels between control and observation group, n (%)
Characteristic | Control group (n = 48) | Observation group (n = 55) | χ2 value | P value |
Metformin treatment | 5.073 | 0.024 | ||
With | 29 (60.42) | 21 (38.18) | ||
Without | 19 (39.58) | 34 (61.82) | ||
HbA1c | 6.980 | 0.008 | ||
> 7.0% | 13 (27.08) | 29 (52.73) | ||
≤ 7.0% | 35 (72.92) | 26 (47.27) |
Table 7 Univariate logistic regression analysis
Characteristic | B | SE | Wals | df | OR | 95%CI | P value |
Age | 0.040 | 0.021 | 3.807 | 1 | 1.041 | 1.000-1.084 | 0.051 |
FBG | 0.368 | 0.081 | 20.418 | 1 | 1.444 | 1.231-1.694 | 0.000 |
TG | 0.506 | 0.259 | 3.826 | 1 | 1.658 | 0.999-2.752 | 0.050 |
LDL-C | 0.673 | 0.343 | 3.853 | 1 | 1.959 | 1.001-3.835 | 0.050 |
BUN | 0.294 | 0.148 | 3.926 | 1 | 1.342 | 1.003-1.794 | 0.048 |
Metformin (with vs without) | -0.905 | 0.405 | 4.989 | 1 | 0.405 | 0.183-0.895 | 0.026 |
HbA1c (> 7.0% vs ≤ 7.0%) | 1.100 | 0.422 | 6.776 | 1 | 3.003 | 1.312-6.872 | 0.009 |
Table 8 Multivariate logistic analysis
Characteristic | B | SE | Wals | df | OR | 95%CI | P value |
FBG | 0.386 | 0.090 | 18.533 | 1 | 1.472 | 1.234-1.755 | 0.000 |
BUN | 0.311 | 0.185 | 2.824 | 1 | 1.365 | 0.950-1.963 | 0.093 |
Metformin (with vs without) | -1.050 | 0.510 | 4.231 | 1 | 0.350 | 0.129-0.952 | 0.040 |
HbA1c (> 7.0% vs ≤ 7.0%) | 1.162 | 0.522 | 4.953 | 1 | 3.197 | 1.149-8.896 | 0.026 |
- Citation: Pan CJ, Wang T, Yin RH, Tang XQ, Hu CH. Coronary imaging characteristics and risk factors in patients with type 2 diabetes mellitus with coronary heart disease complication. World J Diabetes 2025; 16(4): 99151
- URL: https://www.wjgnet.com/1948-9358/full/v16/i4/99151.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i4.99151